IBB ETF holdings (NASDAQ) - Page 7 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

ATAI AtaiBeckley, Inc. 7.65 M 2.16 M 0.09%

TSHA Taysha Gene Therapies, Inc. 7.47 M 1.67 M 0.09%

SION Sionna Therapeutics, Inc. 7.42 M 185.10 K 0.09%

TRVI Trevi Therapeutics, Inc. 7.26 M 608.48 K 0.09%

MESO Mesoblast Ltd. 7.08 M 460.14 K 0.09%

CRVS Corvus Pharmaceuticals, Inc. 6.92 M 473.33 K 0.09%

OLMA Olema Pharmaceuticals, Inc. 6.83 M 457.75 K 0.08%

RAPP Rapport Therapeutics, Inc. 6.81 M 217.76 K 0.08%

QURE uniQure NV 6.76 M 413.70 K 0.08%

GERN Geron Corp. 6.72 M 4.51 M 0.08%

FTRE Fortrea Holdings, Inc. 6.53 M 693.06 K 0.08%

VIR Vir Biotechnology, Inc. 6.31 M 704.45 K 0.08%

XNCR Xencor, Inc. 6.19 M 513.27 K 0.08%

ABCL AbCellera Biologics, Inc. 6.04 M 1.73 M 0.07%

MBX MBX Biosciences, Inc. 5.96 M 199.60 K 0.07%

MAZE Maze Therapeutics, Inc. 5.91 M 197.94 K 0.07%

CDNA CareDx, Inc. 5.87 M 337.89 K 0.07%

TBPH Theravance Biopharma, Inc. 5.74 M 353.65 K 0.07%

GLUE Monte Rosa Therapeutics, Inc. 5.70 M 346.43 K 0.07%

K

KALV KalVista Pharmaceuticals, Inc. 5.57 M 276.92 K 0.07%

1
...
5
6
7
8
9
10
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026